Author:
Önal Uğur,Tüzemen Ülkü,Kaya Pınar K,İşçimen Remzi,Girgin Nermin K,Özakın Cüneyt,Kahveci Ferda,Akalın Halis
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study;Wang M;Lancet Infect Dis,2022
2. Clinical and economic burden of carbapenem-resistant infection or colonization caused by Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii: a multicenter study in China;Zhen X;Antibiotics (Basel),2020
3. Antimicrobial resistance surveillance in Europe 2023 - 2021 data. Stockholm. European Centre for Disease Prevention and Control and World Health Organization; 2023. (2023). Accessed: August 8, 2023: https://www.ecdc.europa.eu/sites/default/files/documents/Antimicrobial%20resistance%20surveillance%20in%20Europe%2020....
4. Republic of Türkiye, Ministry of Health, General Directorate of Public Health, Department of Infectious Diseases and Early Warning. National Healthcare-Associated Infections Surveillance Network (USHİESA) Summary Report 2022. (2022). Accessed. August 8, 2023: https://hsgmdestek.saglik.gov.tr/depo/birimler/Bulasici-hastaliklar-db/hastaliklar/SHIE/Raporlar/USHIESA_OZET_RAPORU_....
5. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by the European Society of Intensive Care Medicine);Paul M;Clin Microbiol Infect,2022